Cargando…
Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients
INTRODUCTION: The European Neuroendocrine Tumor Society, ENETS, reports variables of prognostic significance in pancreatic neuroendocrine tumors (PNET). However, studies have short follow-ups, and the optimal treatment remains controversial. We aimed to determine overall survival (OS), progression-f...
Autores principales: | Krogh, Sara, Grønbæk, Henning, Knudsen, Anders Riegels, Kissmeyer-Nielsen, Peter, Hummelshøj, Nynne Emilie, Dam, Gitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273749/ https://www.ncbi.nlm.nih.gov/pubmed/35837305 http://dx.doi.org/10.3389/fendo.2022.925632 |
Ejemplares similares
-
First-generation somatostatin ligand receptor treatment in a pregnant patient with a neuroendocrine tumor with liver metastases
por: Hummelshøj, Nynne Emilie, et al.
Publicado: (2021) -
Alternative Polyadenylation of Tumor Suppressor Genes in Small Intestinal Neuroendocrine Tumors
por: Rehfeld, Anders, et al.
Publicado: (2014) -
Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
por: Zhuge, Xiaoling, et al.
Publicado: (2020) -
Incidence and Survival of Patients with Small Intestinal Neuroendocrine Tumours in a Danish NET Center
por: Hoej, Lise Brehm, et al.
Publicado: (2012) -
Characteristics, Treatment, Outcomes, and Survival in Neuroendocrine G1 and G2 Pancreatic Tumors: Experiences From a Single Tertiary Referral Center
por: Calissendorff, Jan, et al.
Publicado: (2021)